Natural polysaccharides (NPs), as a class of bioactive macromolecules with multitarget synergistic regulatory potential, exhibit significant advantages in diabetes intervention. This review systematically summarizes the core hypoglycemic mechanisms of NPs, covering structure–activity relationships, integration of the gut microbiota–metabolism–immunity axis, and regulation of key signaling pathways. Studies demonstrate that the molecular weight, branch complexity, and chemical modifications of NPs mediate their hypoglycemic activity by influencing bioavailability and target specificity. NPs improve glucose metabolism through multiple pathways: activating insulin signaling, improving insulin resistance (IR), enhancing glycogen synthesis, inhibiting gluconeogenesis, and regulating gut microbiota homeostasis. Additionally, NPs protect pancreatic β-cell function via the nuclear factor E2-related factor 2 (Nrf2)/Antioxidant Response Element (ARE) antioxidant pathway and Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) anti-inflammatory pathway. Clinical application of NPs still requires overcoming challenges such as resolving complex structure–activity relationships and dynamically integrating cross-organ signaling. Future research should focus on integrating multi-omics technologies (e.g., metagenomics, metabolomics) and organoid models to decipher the cross-organ synergistic action networks of NPs, and promote their translation from basic research to clinical applications.
Diabetes ranks first among non-communicable chronic diseases worldwide, with its incidence rising year on year; this makes the search for safer and more effective drugs an effective strategy. Ophiopogon japonicus (OJ) is a traditional Chinese medicinal herb used to nourish yin, and Ophiopogon japonicus polysaccharides (OJPS) are one of its primary active components. Currently, research into the hypoglycaemic effects of OJPS, particularly in vivo studies of its mechanisms of action, remains limited. This paper provides a systematic review of the structural characteristics of Ophiopogon japonicus polysaccharides and their hypoglycaemic mechanisms in a zebrafish hyperglycaemia model. Structural studies indicate that OJPS (3.929 kDa) is a highly homogeneous, highly soluble, and compact polysaccharide, primarily composed of glucose (91.85%) and galacturonic acid (3.41%). Following treatment with OJPS, hyperglycaemic zebrafish exhibited improvements in both glucose and lipid metabolism parameters. Concurrently, OJPS suppressed oxidative stress in the zebrafish, reducing hepatic lipid accumulation and inflammatory cell infiltration. Furthermore, OJPS significantly increased the expression of GLP-1, cAMP, PKA and phosphorylated CREB (P-CREB) proteins, thereby promoting insulin secretion. In summary, this study demonstrates the dual potential of OJPS in the functional food and pharmaceutical industries.